CellWell record HH-574835
Targeting the Neuro-Immune Axis in Next-Generation Oncology: Discovery and Validation of β2-Adrenergic Blockade to Reverse Ecosystem-Wide Resistance
Heng Xu; Jiaan Lu; Zizhang Wang; Jiayu Xu; Shihui Peng; Haiqing Chen; Qiang Cao; Qing Sun; Shangke Huang
2026
In plain language
This review reports that sympathetic signaling through β2-adrenergic receptors suppresses antitumor immunity, and preclinical evidence suggests β-blockade may enhance checkpoint inhibitor efficacy.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-574835
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.